DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN) (“Lantern” or the “Company”), an AI-driven clinical-stage precision oncology company, today announced the first public demonstration of ...
Hi. This is Craig Brelsford with RedChip Companies. Thank you for joining us for what promises to be an exciting session with Lantern Pharma. Today's session is centered around a live real-time ...
ORLANDO, FL / ACCESS Newswire / April 24, 2026 / RedChip Companies will host a live webinar featuring Lantern Pharma Inc. (NASDAQ:LTRN), an AI-driven clinical-stage precision oncology company, where ...
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (Nasdaq: LTRN) (“Lantern” or the “Company”), an AI-driven clinical-stage precision oncology company, today announced it will host an investor, analyst and ...
Patent-Pending Multi-Agent Architecture Targets Fragmented Biomedical Data and Expands Toward Imaging, Omics, and Broader Health-Data Applications Ahead of Planned AAIC 2026 Demonstration in London ...
ORLANDO, FL / ACCESS Newswire / April 24, 2026 / RedChip Companies will host a live webinar featuring Lantern Pharma Inc. (NASDAQ:LTRN), an AI-driven clinical-stage precision oncology company, where ...
ORLANDO, FL / ACCESS Newswire / April 24, 2026 / RedChip Companies will host a live webinar featuring Lantern Pharma Inc. (NASDAQ:LTRN), an AI-driven clinical-stage precision oncology company, where ...